Cite
MLA Citation
A. Antovic et al.. “SAT0004 Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor - TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome.” Annals of the rheumatic diseases, vol. 73, 2014, p. 591. http://access.bl.uk/ark:/81055/vdc_100135140087.0x000057